These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 15886150)

  • 1. Immunizations in the United States: success, structure, and stress.
    Orenstein WA; Douglas RG; Rodewald LE; Hinman AR
    Health Aff (Millwood); 2005; 24(3):599-610. PubMed ID: 15886150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of measles elimination in development of a national immunization program.
    Orenstein WA
    Pediatr Infect Dis J; 2006 Dec; 25(12):1093-101. PubMed ID: 17133153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric immunization update 2002.
    Paulson PR; Hammer AL
    Pediatr Nurs; 2002; 28(2):173-81. PubMed ID: 11962186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the impact of vaccines postlicensure: new challenges, new opportunities.
    Schuchat A; Bell BP
    Expert Rev Vaccines; 2008 May; 7(4):437-56. PubMed ID: 18444891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financing immunization of adults in the United States.
    Orenstein WA; Mootrey GT; Pazol K; Hinman AR
    Clin Pharmacol Ther; 2007 Dec; 82(6):764-8. PubMed ID: 17971821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations to improve targeted vaccination coverage among high-risk adults.
    Task Force on Community Preventive Services
    Am J Prev Med; 2005 Jun; 28(5 Suppl):231-7. PubMed ID: 15894158
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the impact of wastage on pediatric vaccine immunization formulary costs using a vaccine selection algorithm.
    Jacobson SH; Karnani T; Sewell EC
    Vaccine; 2004 Jun; 22(17-18):2307-15. PubMed ID: 15149790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
    Rodewald LE; Orenstein WA; Mason DD; Cochi SL
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service.
    Hinman AR; Orenstein WA; Schuchat A
    Am J Epidemiol; 2011 Dec; 174(11 Suppl):S16-22. PubMed ID: 22135390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financing immunizations in the United States.
    Hinman AR; Orenstein WA; Rodewald L
    Clin Infect Dis; 2004 May; 38(10):1440-6. PubMed ID: 15156483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The United States pediatric vaccine stockpile program.
    Lane KS; Chu SY; Santoli JM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine shortages: history, impact, and prospects for the future.
    Hinman AR; Orenstein WA; Santoli JM; Rodewald LE; Cochi SL
    Annu Rev Public Health; 2006; 27():235-59. PubMed ID: 16533116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history of vaccines and immunization: familiar patterns, new challenges.
    Stern AM; Markel H
    Health Aff (Millwood); 2005; 24(3):611-21. PubMed ID: 15886151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
    Evans G
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pediatric vaccine recommendations and policies.
    Pickering LK; Orenstein WA
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):148-54. PubMed ID: 12199610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care physician perspectives on reimbursement for childhood immunizations.
    Freed GL; Cowan AE; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1319-24. PubMed ID: 19047252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine preventable diseases and vaccination policy for indigenous populations.
    Menzies RI; Singleton RJ
    Pediatr Clin North Am; 2009 Dec; 56(6):1263-83. PubMed ID: 19962021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.